DataMEDS AI, Inc. (MEDS) Stock

Healthcare · Medical Distribution · Member of Other US Stocks

DataMEDS AI, Inc. (MEDS) closed at USD 2.85 on 2026-10-14, a change of -91.2 % over the past year, with a market capitalization of USD 12.87M.

DataMEDS AI, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

DataMEDS AI, Inc. key figures

Previous close

USD 2.85 (2026-10-14)

1-year change

-91.2 %

Market cap

USD 12.87M

Enterprise value

USD 38.89M

P/E ratio (trailing)

-0.07

P/E ratio (forward)

n/a

EPS (trailing)

-43.37

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-0.41

Revenue growth

-77.2 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.04

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About DataMEDS AI, Inc.

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for DataMEDS AI, Inc. and compare it with other stocks.